1Dhaun N, Goddard J,Webb DJ.The endothelin system and its antagonism in chronic kidney disease [J].J Am Soc Nephrol,2006,17(4): 943-955. 被引量：1
2Rainer B, Thomas K,Claude B,et al. Improvement of Pastischemic acute renal failure with the novel orally active ETA receptor antagonist LU 135252 in the rat [J]. J Cardiovascular Pharmacol,1998,32 ( 1 ):80-84. 被引量：1
3Neuhofer W, Pittrow D. Role of endothelin and endothelin receptor antagonists in renal disease[J]. Eur J Clin Invest,2006,36(3 ):78-88. 被引量：1
4Wesson DE , Simoni J, Prabhakar S. Endothelin-indueed increased nitric oxide mediates augmented distal nephron acidification as a result of dietary protein[J]. J Am Soc Nephrol,2006,17(2): 406-413. 被引量：1
5Forbes JM, Hewitson TD, Becket G J, et al.Simuhaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long term kidney function [J].Kidney Int, 2001,59 (4): 1334-1341. 被引量：1
7Erdogan H, Fadillioglu E, Emre MH. Protection from renal ischemiareperfusion injury by an endothelin-A receptor antagonist BQ-123 in relation to nitric oxide production[J].Toxicology, 2006,228 (2-3): 219-228. 被引量：1
8Peco-Antic A, Nastic-Miric D,Popovic-Rolovic M,et al.Endothelin-1 in act[te renal fallure[J].Ren Fail,1996,18(4):553-556. 被引量：1
9Molet S,Furukawa K,Maghazecki A,et al. Chemokine and cytokineinduced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells [J].J Allergy Clin Immunol,2000,105 (2Pt1):333-338. 被引量：1
1Yanagisawa M, Kurihara H,Kimura S,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells [J].Nature,1988, 332(31): 411-415 被引量：1
2Donald EK. Endothelins in the Normal anddiseased kindney[J].Am J kidney Dis ,1997, 29:2-26 被引量：1
3Hargrove GH,Dufresne J,Whiteside C,et al.Diabetes mellitus increases endothelin-1 gene transcription in rat kidney[].Kidney International.2000 被引量：1
4Ding SS,Qiu C,Hess P,et al.Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat[].Journal of Cardiovascular Pharmacology.2003 被引量：1
5Shin SJ,Lee YJ,Lin SR,et al.Decrease of renal endothelin 1 content and gene expression in diabetic rats with moderate hyperglycemia[].Nephron.1995 被引量：1
6Bakris GL,Bhandaru S,Akerstrom V,et al.ACE inhibitormediated attenuation of mesangial cell growth: a role for endothelin[].American Journal of Hypertension.1994 被引量：1
7Khan MA,Dashwood MR,Mumtaz FH,et al.Upregulation of endothelin A receptor sites in the rabbit diabetic kidney: potential relevance to the early pathogenesis of diabetic nephropathy[].Nephron.1999 被引量：1
8Rrabelink TJ,Bakris GL.The renin-angiotensin system in diabetic nephropathy: the endothelial connection[].Mineral and Electrolyte Metabolism.1998 被引量：1
9Barton M,Carmona R,Krieger JE,et al.Endothelin regulates angiotensin-converting enzyme in the mouse kidney[].Journal of Cardiovascular Pharmacology. 被引量：1
10Zhang SL,To C,Chen X,et al.Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells[].Experimental Nephrology.2001 被引量：1
8Dhaun N, Goddard J, Webb DJ . The Endothelin System and Its Antagonism in Chronic Kidney Disease [ J ]. J Am Soe Nephrol, 2006,17 : 943 -955. 被引量：1
9Perico N, Benigni A, Remuzzi G. Present and future drug treat: ments for chronic kidney diseases: evolving targets in renoprotection [J]. Nat Rev Drug Discov ,2008,7:936 -953. 被引量：1
10Dhann N, Ferro C J, Davenport AP, et al. Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease [ J ]. Nephrol Dial Transplant, 2007,22 : 3228 -3234. 被引量：1
